299 related articles for article (PubMed ID: 25079695)
21. Situated stem cell ethics: beyond good and bad.
Liu JA
Regen Med; 2017 Sep; 12(6):587-591. PubMed ID: 28976823
[No Abstract] [Full Text] [Related]
22. California's vote to revive controversial stem-cell institute sparks debate.
Subbaraman N
Nature; 2020 Nov; 587(7835):535. PubMed ID: 33199902
[No Abstract] [Full Text] [Related]
23. California prepares to roll out stem-cell funding.
Dalton R
Nature; 2005 Oct; 437(7060):800-1. PubMed ID: 16208332
[No Abstract] [Full Text] [Related]
24. Global update: Scotland.
Courtney A
Regen Med; 2011 Nov; 6(6 Suppl):150-2. PubMed ID: 21999279
[TBL] [Abstract][Full Text] [Related]
25. Stem cell research in Latin America: update, challenges and opportunities in a priority research area.
Palma V; Pitossi FJ; Rehen SK; Touriño C; Velasco I
Regen Med; 2015; 10(6):785-98. PubMed ID: 26440367
[TBL] [Abstract][Full Text] [Related]
26. Prospects for translational regenerative medicine.
Chen FM; Zhao YM; Jin Y; Shi S
Biotechnol Adv; 2012; 30(3):658-72. PubMed ID: 22138411
[TBL] [Abstract][Full Text] [Related]
27. Regenerative medicine: a reality of stem cell technology.
Terzic A; Edwards BS; McKee KC; Nelson TJ
Minn Med; 2011 May; 94(5):44-7. PubMed ID: 21707014
[TBL] [Abstract][Full Text] [Related]
28. Lancet Commission: Stem cells and regenerative medicine.
Cossu G; Birchall M; Brown T; De Coppi P; Culme-Seymour E; Gibbon S; Hitchcock J; Mason C; Montgomery J; Morris S; Muntoni F; Napier D; Owji N; Prasad A; Round J; Saprai P; Stilgoe J; Thrasher A; Wilson J
Lancet; 2018 Mar; 391(10123):883-910. PubMed ID: 28987452
[No Abstract] [Full Text] [Related]
29. Industry update: Latest developments in stem cell research and regenerative medicine.
Ilic D
Regen Med; 2013 Nov; 8(6):689-94. PubMed ID: 24147524
[No Abstract] [Full Text] [Related]
30. Centre for Commercialization of Regenerative Medicine: moving forward with regenerative medicine commercialization in Canada.
Johnson S
Stem Cells Dev; 2013 Dec; 22 Suppl 1():85-8. PubMed ID: 24304082
[No Abstract] [Full Text] [Related]
31. Stem cells: Hope on the line.
Hayden EC
Nature; 2014 Jul; 511(7507):19-21. PubMed ID: 24990726
[No Abstract] [Full Text] [Related]
32. The need for a regen industry voice.
Mason C; Dunnill P
Regen Med; 2008 Sep; 3(5):621-31. PubMed ID: 18729785
[No Abstract] [Full Text] [Related]
33. Special focus issue on regenerative medicine in society: interdisciplinary perspectives (part II) - Foreword.
Barfoot J; Rosemann A; Blackburn CC
Regen Med; 2017 Oct; 12(7):733-736. PubMed ID: 29111912
[No Abstract] [Full Text] [Related]
34. Fighting for stem cell research. Interview with Don C Reed.
Reed DC
Regen Med; 2011 Nov; 6(6 Suppl):118-20. PubMed ID: 21999273
[TBL] [Abstract][Full Text] [Related]
35. Accelerating regenerative medicine: the Japanese experiment in ethics and regulation.
Lysaght T
Regen Med; 2017 Sep; 12(6):657-668. PubMed ID: 28976822
[TBL] [Abstract][Full Text] [Related]
36. Stem-cell agency faces budget dilemma.
Hayden EC
Nature; 2012 Jan; 482(7383):15. PubMed ID: 22297945
[No Abstract] [Full Text] [Related]
37. Trachea transplants test the limits.
Vogel G
Science; 2013 Apr; 340(6130):266-8. PubMed ID: 23599456
[No Abstract] [Full Text] [Related]
38. Broadening the scope of debates around stem cell research.
Lysaght T; Campbell AV
Bioethics; 2013 Jun; 27(5):251-6. PubMed ID: 22500617
[TBL] [Abstract][Full Text] [Related]
39. California: 'the Stem Cell State'. Interview with Jonathan Thomas.
Thomas J
Regen Med; 2011 Nov; 6(6 Suppl):113-5. PubMed ID: 21999272
[TBL] [Abstract][Full Text] [Related]
40. Catalyzing stem cell research.
Willemse L; Lyall D; Rudnicki M
Regen Med; 2008 Sep; 3(5):761-4. PubMed ID: 18729799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
